Campos-Aguirre E, Martínez-Álvarez JC, Arrazola-García MA, Arroyo-García OD, Delgado-Colín MG, Chávez-Durán MÁ, Galván-Bobadilla AI, Benítez-Arvizu G. [PCR for COVID in the transplant protocol].
REVISTA MEDICA DEL INSTITUTO MEXICANO DEL SEGURO SOCIAL 2023;
61:S33-S36. [PMID:
36378084 PMCID:
PMC10395893]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Accepted: 07/25/2022] [Indexed: 06/16/2023]
Abstract
Background
Since the beginning of the SARS-CoV-2 pandemic, identifying the COVID-19 pathophysiology not only has been addressed to applying diagnostic tests or preventing through vaccines, but also to the timely detection, especially of patients in risk groups such as those in transplants areas (renal, hematology, etcetera). In the case of these patients, using RT-PCR tests avoids putting them at risk by subjecting them to states of immunosuppression that could aggravate their situation if they were faced with an onset of a COVID-19 infection.
Objective
To present the results of patients of a transplant unit tested for SARS-CoV-2.
Material and methods
Descriptive, observational, cross-sectional, and retrolective study. Data of results of RT-PCR tests of patients who underwent transplantation from June 2021 to April 2022 in a third level hospital were collected.
Results
755 tests were done to patients who underwent transplantation. 384 (50.8%) were women. Out of all patients, only 73 (9.7%) were positive to SARS-CoV-2.
Conclusions
Implementing RT-PCR tests as a transplant protocol to detect SARS-CoV-2 prevents fatal complications due to COVID infection to donors and receptors.
Collapse